describing a study in which researchers recorded dopamine and serotonin levels in the substantia nigra pars reticulata of patients with Parkinson’s disease undergoing DBS surgery. Disclaimer ...
warns that this therapy might cause neuronal death in the substantia nigra (SN) and could predispose individuals to hyperkinetic movement disorders and seizures. Hatzipetros et al. conclude that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback